Procter & Gamble Hygiene and Health Care (500459) Q4 23/24 earnings summary

Executive summary

• Achieved revenue from operations of ₹4,206 crore, up 7% year-over-year, driven by innovation and category growth in feminine hygiene.

• Profit before tax rose to ₹939 crore (up 12%), while profit after tax was ₹675 crore, flat year-over-year due to one-time tax items.

• Operational profit, excluding one-time tax impacts, was ₹809 crore, up 19% year-over-year.

• Maintained focus on integrated growth strategy: product superiority, productivity, constructive disruption, and agile organization.

Financial highlights

• Revenue from operations: ₹4,206 crore (FY23: ₹3,918 crore).

• Profit before tax: ₹939 crore (FY23: ₹839 crore).

• Profit after tax: ₹675 crore (FY23: ₹678 crore).

• EPS: ₹207.95 (FY23: ₹208.91).

• Operating profit margin: 23% (FY23: 22%).

• Cash generated from operations: ₹749 crore.

• Aggregate dividend for FY24: ₹255 per share, including a one-time special dividend.

Outlook and guidance

• RBI projects India's GDP growth at 7.2% for FY25; IMF forecasts inflation to moderate.

• Rural demand expected to improve with above-normal rainfall and government interventions.

• FMCG sector outlook remains positive; company well-positioned for sustained growth.